Follicular Helper T-Cell Lymphoma — Trials

Follicular Helper T-Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 10
Ph III recruiting: 2
Growth YoY: —
Industry share: 24%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–16 of 16 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03590574	Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma	terminated	Phase 1 / Phase 2	20	Autolus LimitedINDUSTRY	2	Mar 16, 2026	clinicaltrials
NCT01769222	Ipilimumab and Local Radiation for Selected Solid Tumors	terminated	Phase 1	3	Stanford UniversityOTHER	1	Jan 24, 2024	clinicaltrials